Clinical Trial Update: Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy of silodosin for symptomatic benign prostatic hyperplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED